India’s Trivitron takes over Dubai JV

Trivitron Healthcare, an integrated healthcare organisation focused on innovation, manufacturing, distribution and patient healthcare delivery, today announced reinforced foray into the Middle East market with converting an existing JV with ETA Star Healthcare into a wholly-owned subsidiary in Dubai.

The JV with the Al Ghurarir Group company was established in 2006 and at the end of 2012, Trivitron acquired it completely setting up its own offices in Dubai Healthcare City to pursue an aggressive growth mandate for its innovative, indigenously manufactured products in the $80 billion Middle East market.

Trivitron in a statement said that as part of its strategic global growth plan, the company has also made a 100 per cent acquisition of the globally renowned Finland-based Anilabsyatem.

The acquisition will also help bring Anilabsystem’s product into the Middle East market,  African and emerging markets apart from Trivitron’s indigenously manufactured, innovative products in critical care and operating room solutions, lab diagnostics (IVD) and X-ray imaging solutions. It will also help leverage collaboration with channel partners and enhance networking for new products in focussed segment.

Commenting on their presence at the Arab Health, Dr. GSK Velu MD and Founder of Trivitron Healthcare, said: “We are glad to enter the emerging markets of the world with our own branded products and solutions. This forum has helped us in establishing our self as globally acclaimed fully integrated medical technology company, focused on innovation, manufacturing, technical service support, patient healthcare delivery and skill education.”

In 2013, Trivitron Healthcare’s focus has been Labsystems’ Neonatal screening system, cardiac biomarkers, infectious disease, gastrointestinal infection (celiac) test, fertility tests and patented products across the segments. Its OEM brands include Lab diagnostics, Critical Care and Operating Room solutions, imaging solutions), Kiran products and Labsystems diagnostics products.

“The strategic partnership has not changed the existing respective distribution relationships but allows both companies to better serve their customers and provide them the products, support and training that they need in their markets” says Timo H Lasola, CEO of Labsystems Diagnostics.

 

Print Email
Comments

Comments